Treatment of neuropathic pain
The present invention relates to the field of neurology. More specifically, the present invention provides methods and composition useful for treating neuropathic pain. In a specific embodiment, the present invention provides a recombinant Kcna2 sense fragment. In another embodiment, the present invention provides a method of treating neuropathic pain comprising the step of administering a composition comprising a recombinant Kcna2 sense fragment.
1. A method for treating neuropathic pain comprising the step of administering to a patient in need thereof a composition comprising a recombinant Kcna2 sense fragment, wherein the recombinant Kcna2 sense fragment comprises SEQ ID NO:6.
2. The method of claim 1 , wherein the composition further comprises a pharmaceutically acceptable carrier.
3. The method of claim 1 , wherein the patient is human.
4. The method of claim 1 , wherein the composition is administered to the dorsal root ganglion or to the spinal cord of the patient.
5. The method of claim 1 , wherein the composition is administered parenterally.
6. A method for treating neuropathic pain comprising the step of administering to a patient in need thereof a composition comprising a recombinant vector encoding a Kcna2 sense fragment shown in SEQ ID NO:6.
7. The method of claim 6 , wherein the composition further comprises a pharmaceutically acceptable carrier.
8. The method of claim 6 , wherein the patient is human.
9. The method of claim 6 , wherein the composition is administered to the dorsal root ganglion or to the spinal cord of the patient.
10. The method of claim 6 , wherein the composition is administered parenterally.